Suono Bio Reports Encouraging Results From First in Human Study of Ultrasound Mediated Drug Delivery Platform

Suono Bio Reports Encouraging Results From a First in Human (FiH) Study of Its Ultrasound Mediated Drug Delivery Platform In a recent study, Suono Bio Inc. has unveiled promising findings from its first clinical trial testing the SuonoCalm™ platform. This groundbreaking study demonstrates the feasibility and safety of using ultrasound for drug delivery in the gastrointestinal tract. The study co..